Bristol-Myers Squibb Sees Growth in Antiviral Therapies


Published On: October 27th, 2010

At a time when cash-strapped U.S. patients are deserting their prescriptions due to sticker shock and debt-laden European governments are trying to control price increases, antiviral agents are giving pharmaceutical executives hope of serious revenue increases.

Read the rest here:
Bristol-Myers Squibb Sees Growth in Antiviral Therapies



Loading...


Comments are closed.